https://m2.mtmt.hu/ hun 2026-09-21 23:45 JournalArticle 36313869 VALIDATED true Funding Agency and Grant Number: Hungarian Academy of Sciences (Momentum) [LP2014-7/2014, 2019-436]; Hungarian Research Network [HUN-REN SA-83/2021]; HUN-REN [TECH-2024-042]; Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund [OTKA-K128262, 2024-2-1-1-EKP-2024-00004, FIEK-16-1-2016-0005, OTKA-K124862, 2020-1.1.2-PIACI-KFI-2021-00273, 2024-1.2.3-HU-RIZONT-2024-00062, 2019-2.1.7-ERANET-2020-00014, 2020-346] Funding text: The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by grants from the Hungarian Academy of Sciences (Momentum LP2014-7/2014 to NGT, Premium postdoc 2019-436 to AB, Young Researcher to ET), the Hungarian Research Network (HUN-REN SA-83/2021 and HUN-REN TECH-2024-042 grant to NGT), and the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, financed under the OTKA-K128262 (to AS), 2024-2-1-1-EKOP-2024-00004 (to MP), FIEK-16-1-2016-0005, OTKA-K124862, 2020-1.1.2-PIACI-KFI-2021-00273, 2024-1.2.3-HU-RIZONT-2024-00062 and 2019-2.1.7-ERANET-2020-00014 (all to NGT) funding schemes, the latter under the frame of the European Union ERA PerMed (2020-346 grant). 0 false 2026-08-13T13:13:50.723+0000 2026-05-30T17:14:06.327+0000 2025-09-02T09:46:27.362+0000 true 10034624 Nagy Sándor /api/author/10034624 Author Nagy Sándor (szülészet-nőgyógyászat) true 10034624 2026-07-09T11:01:11.456+0000 2026-07-09T11:01:11.456+0000 2025-12-16T12:41:55.755+0000 true 10098493 Makkai Csilla /api/admin/10098493 Admin Makkai Csilla (SZE Szakreferens, admin) true 2025-12-23T00:43:00.601+0000 true 521 Szuper Admin /api/admin/521 Admin Szuper Admin (admin) true Admin 10025544 /api/admin/10025544 Lévayné Deseő Katalin (MTMT Központi admin) Lévayné Deseő Katalin true 10025544 true 2026-05-28T10:32:47.093+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Tóth, Eszter true true /api/journal/10023324 REVIEWED FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224 true false 10023324 false 10023324 true 1664-3224 1664-3224 Journal FOREIGN 16 1621168 1621168 18 2025 Funding 2057430 /api/funding/2057430 (LP2014-7/2014,) false true Funding 2057431 /api/funding/2057431 (HUN-REN SA-83/2021) Támogató: HUN_REN false true Funding 2057432 /api/funding/2057432 (K128262) false true Funding 2057433 /api/funding/2057433 (2024-2-1-1-EKÖP-2024-00004) false true Funding 2057434 /api/funding/2057434 (FIEK-16-1-2016-0005) false true Funding 2057435 /api/funding/2057435 (K124862) false true Funding 2057436 /api/funding/2057436 Piacvezérelt kutatás-fejlesztési és innovációs projektek támogatása(2020-1.1.2-PIACI-KFI-2021-00273) Támogató: Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal false true Funding 2057437 /api/funding/2057437 (2024-1.2.3-HU-RIZONT-2024-00062) false true Funding 2057438 /api/funding/2057438 (2019-2.1.7-ERANET-2020-00014) false true Funding 2057439 /api/funding/2057439 ERA PerMed(2020-346 grant) Támogató: EU false true true true 2025 true true true false true false GOLD 2026-08-13 false http://www.frontiersin.org/immunology 3 0 3 3 0 3 3 2 3 3 3 3 3 3 0 0 3 3 3 3 0 16 16 Folyóiratcikk Journal Article 24 3 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2026 0 3 3 3 3 Q1 false false false false 2025-09-22T05:54:44.464+0000 Bioinformatika Tanszék (SE / AOK / I); Biológia Doktori Iskola (ELTE / TTK); Doktori Iskola (SE); Információs Technológiai és Bionikai Kar (PPKE); Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI); Molekuláris Élettudományi Intézet (HRN TTK); Szülészeti és Nőgyógyászati Klinika Baross utca... (SE / AOK / K / SZSZNK); Szülészeti és Nőgyógyászati Klinika Üllői úti r... (SE / AOK / K / SZSZNK); Szülészeti és Nőgyógyászati Tanszék (SZE / ESK) 11 61 9 18 0 true 10025544 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 127713237 /api/authorship/127713237 Tóth, Eszter [Tóth, Eszter (Proteomika), szerző] Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI) 1 0.056 true false false Author 10025667 /api/author/10025667 Tóth Eszter (Proteomika) Tóth Eszter true 10025667 true Tóth Eszter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705145 /api/authorship/127705145 Posta, Máté* [Posta, Máté (Szülészet- és nőg...), szerző] Doktori Iskola (SE); Bioinformatika Tanszék (SE / AOK / I); Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI) 2 0.056 true false false Author 10082656 /api/author/10082656 Posta Máté (Szülészet- és nőgyógyászat) Posta Máté true true Posta Máté true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705146 /api/authorship/127705146 Györffy, Dániel [Györffy, Dániel (Bioinformatika), szerző] Információs Technológiai és Bionikai Kar (PPKE); Molekuláris Élettudományi Intézet (HRN TTK) 3 0.056 false false false Author 10019484 /api/author/10019484 Györffy Dániel (Bioinformatika) Györffy Dániel true 10019484 true Györffy Dániel true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705147 /api/authorship/127705147 Oravecz, Orsolya [Oravecz, Orsolya (biológia, immunol...), szerző] Biológia Doktori Iskola (ELTE / TTK) 4 0.055555556 false false false Author 10081331 /api/author/10081331 Oravecz Orsolya (biológia, immunológia, molekuláris biológia, mikrobiológia) Oravecz Orsolya true true Oravecz Orsolya true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705148 /api/authorship/127705148 Farkas, Emese [Farkas, Emese (reproduktív immun...), szerző] Doktori Iskola (SE); Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI) 5 0.056 false false false Author 10100038 /api/author/10100038 Farkas Emese (reproduktív immunológia) Farkas Emese true true Farkas Emese true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705149 /api/authorship/127705149 Balogh, Andrea [Balogh, Andrea (Immunológia), szerző] 6 0.055555556 false false false Author 10019319 /api/author/10019319 Balogh Andrea (Immunológia) Balogh Andrea true 10019319 true Balogh Andrea true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705150 /api/authorship/127705150 Escher, Claudia 7 0.055555556 false false false Escher Claudia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705151 /api/authorship/127705151 Bober, Magdalena 8 0.055555556 false false false Bober Magdalena true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705152 /api/authorship/127705152 Szilágyi, András [Szilágyi, András (Bioinformatika), szerző] Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI) 9 0.056 false false false Author 10010376 /api/author/10010376 Szilágyi András (Bioinformatika) Szilágyi András true 10010376 true Szilágyi András true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705153 /api/authorship/127705153 Hupuczi, Petronella 10 0.055555556 false false false Hupuczi Petronella true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705154 /api/authorship/127705154 Veress, Lajos 11 0.055555556 false false false Veress Lajos true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705155 /api/authorship/127705155 Török, Olga 12 0.055555556 false false false Török Olga true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705156 /api/authorship/127705156 Nagy, Sándor [Nagy, Sándor (szülészet-nőgyógy...), szerző] Szülészeti és Nőgyógyászati Tanszék (SZE / ESK) 13 0.056 false false false Author 10034624 /api/author/10034624 Nagy Sándor (szülészet-nőgyógyászat) Nagy Sándor true 10034624 true Nagy Sándor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705157 /api/authorship/127705157 Rinner, Oliver 14 0.055555556 false false false Rinner Oliver true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705158 /api/authorship/127705158 Erez, Offer 15 0.055555556 false false false Erez Offer true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705159 /api/authorship/127705159 Papp, Zoltán [Papp, Zoltán (Szülészet-nőgyógy...), szerző] Szülészeti és Nőgyógyászati Klinika Baross utca... (SE / AOK / K / SZSZNK) 16 0.056 false false false Author 1373182 /api/author/1373182 Papp Zoltán (Szülészet-nőgyógyászat, klinikai genetika) Papp Zoltán true 1373182 true Papp Zoltán true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705160 /api/authorship/127705160 Ács, Nándor [Ács, Nándor (Szülészet-nőgyógy...), szerző] Szülészeti és Nőgyógyászati Klinika Üllői úti r... (SE / AOK / K / SZSZNK) 17 0.056 false false false Author 10013998 /api/author/10013998 Ács Nándor (Szülészet-nőgyógyászat) Ács Nándor true 10013998 true Ács Nándor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 127705161 /api/authorship/127705161 Than, Nándor Gábor ✉ [Than, Nándor Gábor (Rendszerbiológia), szerző] Szülészeti és Nőgyógyászati Klinika Baross utca... (SE / AOK / K / SZSZNK); Lendület Reprodukció Rendszerbiológiája Kutatóc... (HRN TTK / MÉI); Molekuláris Élettudományi Intézet (HRN TTK) 18 0.056 false true true Author 10011696 /api/author/10011696 Than Nándor Gábor (Rendszerbiológia) Than Nándor Gábor true 10011696 true Than Nándor Gábor true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 29783686 /api/publicationidentifier/29783686 DOI: 10.3389/fimmu.2025.1621168 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.3389/fimmu.2025.1621168 https://doi.org/10.3389/fimmu.2025.1621168 false true PublicationIdentifier 29882261 /api/publicationidentifier/29882261 WoS: 001569279100001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001569279100001 https://www.webofscience.com/wos/woscc/full-record/001569279100001 true true PublicationIdentifier 29882253 /api/publicationidentifier/29882253 Scopus: 105015399247 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 105015399247 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105015399247 true true PublicationIdentifier 29885021 /api/publicationidentifier/29885021 PubMed: 40948775 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 40948775 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40948775&dopt=Abstract false true PublicationIdentifier 30213818 /api/publicationidentifier/30213818 Egyéb URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-105015399247&doi=10.3389%2ffimmu.2025.1621168&partnerID=40&md5=590f1db41dbcdf3ff44276a5ef667e8e PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true NONE IDENTICAL https://www.scopus.com/inward/record.uri?eid=2-s2.0-105015399247&doi=10.3389%2ffimmu.2025.1621168&partnerID=40&md5=590f1db41dbcdf3ff44276a5ef667e8e https://www.scopus.com/inward/record.uri?eid=2-s2.0-105015399247&doi=10.3389%2ffimmu.2025.1621168&partnerID=40&md5=590f1db41dbcdf3ff44276a5ef667e8e false true PublicationIdentifier 31968934 /api/publicationidentifier/31968934 Egyéb URL: https://www.scopus.com/pages/publications/105015399247?origin=resultslist PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true NONE IDENTICAL https://www.scopus.com/pages/publications/105015399247?origin=resultslist https://www.scopus.com/pages/publications/105015399247?origin=resultslist false true SjrRating 11591340 /api/sjrrating/11591340 sjr:Q1 (2025) Scopus - Immunology FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224 37 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2403 /api/classificationexternal/2403 Scopus - Immunology true 2403 true Q1 DIRECT true true Reference 67818004 /api/reference/67818004 1. Dugas 2020: Miscarriage., StatPearls 1 false true Reference 67818005 /api/reference/67818005 2. 1977: WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976., Acta Obstet Gynecol Scand, 56, DOI: 10.3109/00016347709162009 2 10.3109/00016347709162009 false true Reference 67818006 /api/reference/67818006 3. Ammon Avalos 2012: A systematic review to calculate background miscarriage rates using life table analysis., Birth Defects Res A Clin Mol Teratol, 94, DOI: 10.1002/bdra.23014 3 10.1002/bdra.23014 false true Reference 67818007 /api/reference/67818007 4. Larsen 2013: New insights into mechanisms behind miscarriage., BMC Med, 11, p. 154, DOI: 10.1186/1741-7015-11-154 4 10.1186/1741-7015-11-154 false true Reference 67818008 /api/reference/67818008 5. Savitz 2002: Epidemiologic measures of the course and outcome of pregnancy., Epidemiol Rev, 24, p. 91, DOI: 10.1093/epirev/mxf006 5 10.1093/epirev/mxf006 false true Reference 67818009 /api/reference/67818009 6. Ford 2009: Recurrent pregnancy loss: etiology, diagnosis, and therapy., Rev Obstet Gynecol, 2, p. 76 6 false true Reference 67818010 /api/reference/67818010 7. Zinaman 1996: Estimates of human fertility and pregnancy loss., Fertil Steril, 65, DOI: 10.1016/S0015-0282(16)58144-8 7 10.1016/S0015-0282(16)58144-8 false true Reference 67818011 /api/reference/67818011 8. Ellish 1996: A prospective study of early pregnancy loss., Hum Reprod, 11, DOI: 10.1093/HUMREP/11.2.406 8 10.1093/HUMREP/11.2.406 false true Reference 67818012 /api/reference/67818012 9. Wilcox 1988: Incidence of early loss of pregnancy., New Engl J Med, 319, DOI: 10.1056/NEJM198807283190401 9 10.1056/NEJM198807283190401 false true Reference 67818013 /api/reference/67818013 10. Rai 2006: Recurrent miscarriage., Lancet, 368, DOI: 10.1016/S0140-6736(06)69204-0 10 10.1016/S0140-6736(06)69204-0 false true Reference 67818014 /api/reference/67818014 11. Chard 1991: 11 Frequency of implantation and early pregnancy loss in natural cycles., Baillière’s Clin Obstet Gynaecol, 5, DOI: 10.1016/S0950-3552(05)80077-X 11 10.1016/S0950-3552(05)80077-X false true Reference 67818015 /api/reference/67818015 12. Macklon 2002: Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss., Hum Reprod Update, 8, DOI: 10.1093/humupd/8.4.333 12 10.1093/humupd/8.4.333 false true Reference 67818016 /api/reference/67818016 13. Brezina 2014: Classic and cutting-edge strategies for the management of early pregnancy loss., Obstet Gynecol Clin North Am, 41, p. 1, DOI: 10.1016/j.ogc.2013.10.011 13 10.1016/j.ogc.2013.10.011 false true Reference 67818017 /api/reference/67818017 14. Regan 1989: Influence of past reproductive performance on risk of spontaneous abortion., Br Med J, 299, p. 541, DOI: 10.1136/bmj.299.6698.541 14 10.1136/bmj.299.6698.541 false true Reference 67818018 /api/reference/67818018 15. Knudsen 1991: Prognosis of a new pregnancy following previous spontaneous abortions., Eur J Obstet Gynecol Reprod Biol, 39, DOI: 10.1016/0028-2243(91)90138-B 15 10.1016/0028-2243(91)90138-B false true Reference 67818019 /api/reference/67818019 16. Vaiman 2015: Genetic regulation of recurrent spontaneous abortion in humans., Biomed J, 38, p. 11, DOI: 10.4103/2319-4170.133777 16 10.4103/2319-4170.133777 false true Reference 67818020 /api/reference/67818020 17. 2002: ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists., Int J Gynecol Obstet, 78, DOI: 10.1016/S0020-7292(02)00197-2 17 10.1016/S0020-7292(02)00197-2 false true Reference 67818021 /api/reference/67818021 18. Li 2002: Recurrent miscarriage: aetiology, management and prognosis., Hum Reprod Update, 8, DOI: 10.1093/humupd/8.5.463 18 10.1093/humupd/8.5.463 false true Reference 67818022 /api/reference/67818022 19. Clifford 1994: An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases., Hum Reprod, 9, DOI: 10.1093/oxfordjournals.humrep.a138703 19 10.1093/oxfordjournals.humrep.a138703 false true Reference 67818023 /api/reference/67818023 20. Stirrat 1990: Recurrent miscarriage., Lancet, 336, DOI: 10.1016/0140-6736(90)92159-F 20 10.1016/0140-6736(90)92159-F false true Reference 67818024 /api/reference/67818024 21. 2012: Evaluation and treatment of recurrent pregnancy loss: a committee opinion., Fertil Steril, 98, DOI: 10.1016/j.fertnstert.2012.06.048 21 10.1016/j.fertnstert.2012.06.048 false true Reference 67818025 /api/reference/67818025 22. Risch 1988: Risk factors for spontaneous abortion and its recurrence., Am J Epidemiol, 128, DOI: 10.1093/oxfordjournals.aje.a114982 22 10.1093/oxfordjournals.aje.a114982 false true Reference 67818026 /api/reference/67818026 23. van den Akker 2011: The psychological and social consequences of miscarriage., Expert Rev Obstet Gynecol, 6, p. 295, DOI: 10.1586/eog.11.14 23 10.1586/eog.11.14 false true Reference 67818027 /api/reference/67818027 24. Murphy 2017: The psychological, social, and economic impact of stillbirth on families., Semin Fetal Neonatal Med, 22, DOI: 10.1016/j.siny.2017.02.002 24 10.1016/j.siny.2017.02.002 false true Reference 67818028 /api/reference/67818028 25. Giorlandino 1998: Spermatozoa with chromosomal abnormalities may result in a higher rate of recurrent abortion., Fertil Steril, 70, DOI: 10.1016/S0015-0282(98)00192-7 25 10.1016/S0015-0282(98)00192-7 false true Reference 67818029 /api/reference/67818029 26. Rubio 2003: Chromosomal abnormalities and embryo development in recurrent miscarriage couples., Hum Reprod, 18, DOI: 10.1093/humrep/deg015 26 10.1093/humrep/deg015 false true Reference 67818030 /api/reference/67818030 27. Stirrat 1990: Recurrent miscarriage II: clinical associations, causes, and management., Lancet, 336, DOI: 10.1016/0140-6736(90)92215-4 27 10.1016/0140-6736(90)92215-4 false true Reference 67818031 /api/reference/67818031 28. Tulppala 1993: A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies., Hum Reprod, 8, DOI: 10.1093/oxfordjournals.humrep.a138137 28 10.1093/oxfordjournals.humrep.a138137 false true Reference 67818032 /api/reference/67818032 29. Uehara 2001: Preferential X-chromosome inactivation in women with idiopathic recurrent pregnancy loss., Fertil Steril, 76, DOI: 10.1016/S0015-0282(01)02845-X 29 10.1016/S0015-0282(01)02845-X false true Reference 67818033 /api/reference/67818033 30. Aldrich 2001: HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage., Mol Hum Reprod, 7, DOI: 10.1093/molehr/7.12.1167 30 10.1093/molehr/7.12.1167 false true Reference 67818034 /api/reference/67818034 31. Grimbizis 2001: Clinical implications of uterine malformations and hysteroscopic treatment results., Hum Reprod Update, 7, DOI: 10.1093/humupd/7.2.161 31 10.1093/humupd/7.2.161 false true Reference 67818035 /api/reference/67818035 32. Salim 2003: A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage., Hum Reprod, 18, DOI: 10.1093/humrep/deg030 32 10.1093/humrep/deg030 false true Reference 67818036 /api/reference/67818036 33. Homer 2000: The septate uterus: a review of management and reproductive outcome., Fertil Steril, 73, p. 1, DOI: 10.1016/S0015-0282(99)00480-X 33 10.1016/S0015-0282(99)00480-X false true Reference 67818037 /api/reference/67818037 34. Clifford 1999: Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study., Hum Reprod, 14, DOI: 10.1093/humrep/14.11.2727 34 10.1093/humrep/14.11.2727 false true Reference 67818038 /api/reference/67818038 35. Quenby 1999: Pre-implantation endometrial leukocytes in women with recurrent miscarriage., Hum Reprod, 14, DOI: 10.1093/humrep/14.9.2386 35 10.1093/humrep/14.9.2386 false true Reference 67818039 /api/reference/67818039 36. Lachapelle 1996: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion altered profile pregnancy outcome., J Immunol, 156, p. 4027, DOI: 10.4049/jimmunol.156.10.4027 36 10.4049/jimmunol.156.10.4027 false true Reference 67818040 /api/reference/67818040 37. Eblen 2000: Alterations in humoral immune responses associated with recurrent pregnancy loss., Fertil Steril, 73, DOI: 10.1016/S0015-0282(99)00505-1 37 10.1016/S0015-0282(99)00505-1 false true Reference 67818041 /api/reference/67818041 38. Wilson 2001: Abnormal immunoglobulin subclass patterns in women with a history of recurrent miscarriage., Fertil Steril, 76, DOI: 10.1016/S0015-0282(01)02857-6 38 10.1016/S0015-0282(01)02857-6 false true Reference 67818042 /api/reference/67818042 39. Makhseed 2001: Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions., Hum Reprod, 16, DOI: 10.1093/humrep/16.10.2219 39 10.1093/humrep/16.10.2219 false true Reference 67818043 /api/reference/67818043 40. Quack 2001: Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion., Hum Reprod, 16, DOI: 10.1093/humrep/16.5.949 40 10.1093/humrep/16.5.949 false true Reference 67818044 /api/reference/67818044 41. Hirahara 1998: Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials., Fertil Steril, 70, DOI: 10.1016/S0015-0282(98)00164-2 41 10.1016/S0015-0282(98)00164-2 false true Reference 67818045 /api/reference/67818045 42. Garzia 2004: Lack of expression of endometrial prolactin in early implantation failure: a pilot study., Hum Reprod, 19, DOI: 10.1093/humrep/deh350 42 10.1093/humrep/deh350 false true Reference 67818046 /api/reference/67818046 43. Craig 2002: Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss., Fertil Steril, 78, DOI: 10.1016/S0015-0282(02)03247-8 43 10.1016/S0015-0282(02)03247-8 false true Reference 67818047 /api/reference/67818047 44. Li 2000: Endocrinological and endometrial factors in recurrent miscarriage., BJOG: Int J Obstet Gynaecol, 107, DOI: 10.1111/j.1471-0528.2000.tb11670.x 44 10.1111/j.1471-0528.2000.tb11670.x false true Reference 67818048 /api/reference/67818048 45. Bussen 1999: Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion., Hum Reprod, 14, p. 18, DOI: 10.1093/humrep/14.1.18 45 10.1093/humrep/14.1.18 false true Reference 67818049 /api/reference/67818049 46. Kovalevsky 2004: Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: A meta-analysis., Arch Internal Med, 164, DOI: 10.1001/archinte.164.5.558 46 10.1001/archinte.164.5.558 false true Reference 67818050 /api/reference/67818050 47. Rey 2003: Thrombophilic disorders and fetal loss: a meta-analysis., Lancet, 361, DOI: 10.1016/S0140-6736(03)12771-7 47 10.1016/S0140-6736(03)12771-7 false true Reference 67818051 /api/reference/67818051 48. Rai 2002: Factor V Leiden and recurrent miscarriage—prospective outcome of untreated pregnancies., Hum Reprod, 17, DOI: 10.1093/humrep/17.2.442 48 10.1093/humrep/17.2.442 false true Reference 67818052 /api/reference/67818052 49. Rai 2001: Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage., Hum Reprod, 16, DOI: 10.1093/humrep/16.5.961 49 10.1093/humrep/16.5.961 false true Reference 67818053 /api/reference/67818053 50. Rai 1995: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies., Hum Reprod, 10, DOI: 10.1093/oxfordjournals.humrep.a135907 50 10.1093/oxfordjournals.humrep.a135907 false true Reference 67818054 /api/reference/67818054 51. Rai 1995: Immunology: Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach., Hum Reprod, 10, DOI: 10.1093/oxfordjournals.humrep.a136224 51 10.1093/oxfordjournals.humrep.a136224 false true Reference 67818055 /api/reference/67818055 52. Greaves 2000: Guidelines on the investigation and management of the antiphospholipid syndrome., Br J Haematol, 109, DOI: 10.1046/j.1365-2141.2000.02069.x 52 10.1046/j.1365-2141.2000.02069.x false true Reference 67818056 /api/reference/67818056 53. Tanimura 2024: Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-beta2-glycoprotein I/HLA-DR autoantibodies: a prospective, multicenter, observational study., Front Immunol, 15, DOI: 10.3389/fimmu.2024.1445852 53 10.3389/fimmu.2024.1445852 false true Reference 67818057 /api/reference/67818057 54. Christiansen 2008: Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications., Gynecol Obstet Invest, 66, DOI: 10.1159/000149575 54 10.1159/000149575 false true Reference 67818058 /api/reference/67818058 55. Heuser 2010: Idiopathic recurrent pregnancy loss recurs at similar gestational ages., Am J Obstet Gynecol, 203, DOI: 10.1016/j.ajog.2010.05.010 55 10.1016/j.ajog.2010.05.010 false true Reference 67818059 /api/reference/67818059 56. Yan 2012: Consecutive repeat miscarriages are likely to occur in the same gestational period., Reprod Biomed Online, 24, DOI: 10.1016/j.rbmo.2012.03.003 56 10.1016/j.rbmo.2012.03.003 false true Reference 67818060 /api/reference/67818060 57. Ticconi 2016: Gestational age of pregnancy loss in women with unexplained recurrent miscarriage., J Obstet Gynaecol Res, 42, DOI: 10.1111/jog.12903 57 10.1111/jog.12903 false true Reference 67818061 /api/reference/67818061 58. Baird 2009: The gestational timing of pregnancy loss: adaptive strategy., Am J Hum Biol, 21, DOI: 10.1002/ajhb.20935 58 10.1002/ajhb.20935 false true Reference 67818062 /api/reference/67818062 59. Piccinni 2021: Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction., Front Immunol, 12, DOI: 10.3389/fimmu.2021.717808 59 10.3389/fimmu.2021.717808 false true Reference 67818063 /api/reference/67818063 60. Blois 2011: Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells., J Reprod Immunol, 88, p. 86, DOI: 10.1016/j.jri.2010.11.002 60 10.1016/j.jri.2010.11.002 false true Reference 67818064 /api/reference/67818064 61. Blois 2017: NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface., Sci Rep, 7, p. 2189, DOI: 10.1038/s41598-017-02333-8 61 10.1038/s41598-017-02333-8 false true Reference 67818065 /api/reference/67818065 62. Vomstein 2021: Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art., J Clin Med, 10, DOI: 10.3390/jcm10040869 62 10.3390/jcm10040869 false true Reference 67818066 /api/reference/67818066 63. Yang 2022: The update immune-regulatory role of pro- and anti-inflammatory cytokines in recurrent pregnancy losses., Int J Mol Sci, 24, p. 132, DOI: 10.3390/ijms24010132 63 10.3390/ijms24010132 false true Reference 67818067 /api/reference/67818067 64. Trout 2000: Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values., Fertil Steril, 74, DOI: 10.1016/s0015-0282(00)00625-7 64 10.1016/s0015-0282(00)00625-7 false true Reference 67818068 /api/reference/67818068 65. Gürbüz 2004: High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss., Arch Gynaecol Obstet, 270, DOI: 10.1007/s00404-003-0490-0 65 10.1007/s00404-003-0490-0 false true Reference 67818069 /api/reference/67818069 66. Pils 2016: Decreased ovarian reserve predicts inexplicability of recurrent miscarriage? A retrospective analysis., PloS One, 11, DOI: 10.1371/journal.pone.0161606 66 10.1371/journal.pone.0161606 false true Reference 67818070 /api/reference/67818070 67. Okon 1998: Serum Androgen Levels in Women who Have Recurrent Miscarriages and their Correlation with Markers of Endometrial Function 11Supported by a research grant from the Special Trustees of the former United Sheffield Hospitals, Royal Hallamshire Hospital, Sheffield, Yorkshire, United Kingdom., Fertil Steril, 69, DOI: 10.1016/S0015-0282(98)00007-7 67 10.1016/S0015-0282(98)00007-7 false true Reference 67818071 /api/reference/67818071 68. Kim 2011: ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients., Mol BioSystems, 7, DOI: 10.1039/c0mb00219d 68 10.1039/c0mb00219d false true Reference 67818072 /api/reference/67818072 69. Ogasawara 1997: Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies., Fertil Steril, 68, DOI: 10.1016/s0015-0282(97)00328-2 69 10.1016/s0015-0282(97)00328-2 false true Reference 67818073 /api/reference/67818073 70. Wu 2017: Serum biomarker analysis in patients with recurrent spontaneous abortion., Mol Med Rep, 16, DOI: 10.3892/mmr.2017.6890 70 10.3892/mmr.2017.6890 false true Reference 67818074 /api/reference/67818074 71. Cui 2019: iTRAQ and PRM-based quantitative proteomics in early recurrent spontaneous abortion: biomarkers discovery., Clin Proteomics, 16, p. 36, DOI: 10.1186/s12014-019-9256-y 71 10.1186/s12014-019-9256-y false true Reference 67818075 /api/reference/67818075 72. Al-Azemi 2003: Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss., Fertil Steril, 80, DOI: 10.1016/S0015-0282(03)02215-5 72 10.1016/S0015-0282(03)02215-5 false true Reference 67818076 /api/reference/67818076 73. Liu 2016: Predictive value of serum β-hCG for early pregnancy outcomes among women with recurrent spontaneous abortion., Int J Gynecology Obstetrics, 135, p. 16, DOI: 10.1016/j.ijgo.2016.03.007 73 10.1016/j.ijgo.2016.03.007 false true Reference 67818077 /api/reference/67818077 74. Muttukrishna 2002: Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages., Hum Reprod, 17, DOI: 10.1093/humrep/17.12.3072 74 10.1093/humrep/17.12.3072 false true Reference 67818078 /api/reference/67818078 75. Rull 2005: Expression of β-subunit of HCG genes during normal and failed pregnancy., Hum Reprod, 20, DOI: 10.1093/humrep/dei261 75 10.1093/humrep/dei261 false true Reference 67818079 /api/reference/67818079 76. Darwish 2005: Biochemical markers for prediction of pregnancy outcome in cases of recurrent pregnancy loss., Conf Proc, 10 76 false true Reference 67818080 /api/reference/67818080 77. Heinig 2007: Maternal serum free ß-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities., Prenat Diagn, 27, DOI: 10.1002/pd.1779 77 10.1002/pd.1779 false true Reference 67818081 /api/reference/67818081 78. Kato 2002: Human chorionic gonadotropin exhibits normal biological activity in patients with recurrent pregnancy loss., Gynecol Endocrinol, 16, DOI: 10.1080/gye.16.3.179.186 78 10.1080/gye.16.3.179.186 false true Reference 67818082 /api/reference/67818082 79. Prakash 2005: Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage., Fertil Steril, 83, DOI: 10.1016/j.fertnstert.2004.11.072 79 10.1016/j.fertnstert.2004.11.072 false true Reference 67818083 /api/reference/67818083 80. Bao 2013: Increased Dickkopf-1 expression in patients with unexplained recurrent spontaneous miscarriage., Clin Exp Immunol, 172, DOI: 10.1111/cei.12066 80 10.1111/cei.12066 false true Reference 67818084 /api/reference/67818084 81. Rull 2013: Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage., Placenta, 34, DOI: 10.1016/j.placenta.2012.11.032 81 10.1016/j.placenta.2012.11.032 false true Reference 67818085 /api/reference/67818085 82. Pang 2013: An increase in vascular endothelial growth factor (VEGF) and VEGF soluble receptor-1 (sFlt-1) are associated with early recurrent spontaneous abortion., PloS One, 8, DOI: 10.1371/journal.pone.0075759 82 10.1371/journal.pone.0075759 false true Reference 67818086 /api/reference/67818086 83. Laird 2001: Leptin and leptin-binding activity in women with recurrent miscarriage: correlation with pregnancy outcome., Hum Reprod, 16, DOI: 10.1093/humrep/16.9.2008 83 10.1093/humrep/16.9.2008 false true Reference 67818087 /api/reference/67818087 84. Hassan 2014: Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss., Asian Pacific J Reprod, 3, DOI: 10.1016/S2305-0500(13)60181-5 84 10.1016/S2305-0500(13)60181-5 false true Reference 67818088 /api/reference/67818088 85. Christiansen 2005: Evidence-based investigations and treatments of recurrent pregnancy loss., Fertil Steril, 83, DOI: 10.1016/j.fertnstert.2004.12.018 85 10.1016/j.fertnstert.2004.12.018 false true Reference 67818089 /api/reference/67818089 86. Christiansen 2006: Evidence-based investigations and treatments of recurrent pregnancy loss., Curr Opin Obstet Gynecol, 18, DOI: 10.1097/01.gco.0000193011.73405.07 86 10.1097/01.gco.0000193011.73405.07 false true Reference 67818090 /api/reference/67818090 87. 2015: The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss., Obstet Gynecol, 125, DOI: 10.1097/01.AOG.0000465191.27155.25 87 10.1097/01.AOG.0000465191.27155.25 false true Reference 67818091 /api/reference/67818091 88. Toth 2024: Decreased expression of placental proteins in recurrent pregnancy loss: functional relevance and diagnostic value., Int J Mol Sci, 25, DOI: 10.3390/ijms25031865 88 10.3390/ijms25031865 false true Reference 67818092 /api/reference/67818092 89. Callister 2006: Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics., J Proteome Res, 5, DOI: 10.1021/pr050300l 89 10.1021/pr050300l false true Reference 67818093 /api/reference/67818093 90. Than 2018: Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia., Front Immunol, 9, DOI: 10.3389/fimmu.2018.01661 90 10.3389/fimmu.2018.01661 false true Reference 67818094 /api/reference/67818094 91. Szilagyi 2020: Placenta-specific genes, their regulation during villous trophoblast differentiation and dysregulation in preterm preeclampsia., Int J Mol Sci, 21, DOI: 10.3390/ijms21020628 91 10.3390/ijms21020628 false true Reference 67818095 /api/reference/67818095 92. Storey 2002: A direct approach to false discovery rates., J R Stat Society: Ser B (Statistical Methodology), 64, DOI: 10.1111/1467-9868.00346 92 10.1111/1467-9868.00346 false true Reference 67818096 /api/reference/67818096 93. Tal 2000: Endocrinology of pregnancy., Endotext 93 false true Reference 67818097 /api/reference/67818097 94. Csapo 1978: Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence., Obstet Gynecol Surv, 33, p. 69, DOI: 10.1097/00006254-197802000-00001 94 10.1097/00006254-197802000-00001 false true Reference 67818098 /api/reference/67818098 95. Jauniaux 2000: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure., Am J Pathology, 157, DOI: 10.1016/S0002-9440(10)64849-3 95 10.1016/S0002-9440(10)64849-3 false true Reference 67818099 /api/reference/67818099 96. Szklarczyk 2023: The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest., Nucleic Acids Res, 51, DOI: 10.1093/nar/gkac1000 96 10.1093/nar/gkac1000 false true Reference 67818100 /api/reference/67818100 97. Aleksander 2023: The gene ontology knowledgebase in 2023., Genetics, 224, DOI: 10.1093/genetics/iyad031 97 10.1093/genetics/iyad031 false true Reference 67818101 /api/reference/67818101 98. Burton 2015: What is the placenta., Am J Obstet Gynecol, 213, DOI: 10.1016/j.ajog.2015.07.050 98 10.1016/j.ajog.2015.07.050 false true Reference 67818102 /api/reference/67818102 99. Khorami-Sarvestani 2024: Placenta: an old organ with new functions., Front Immunol, 15, DOI: 10.3389/fimmu.2024.1385762 99 10.3389/fimmu.2024.1385762 false true Reference 67818103 /api/reference/67818103 100. Crowley 2013: Liquid biopsy: monitoring cancer-genetics in the blood., Nat Rev Clin Oncol, 10, DOI: 10.1038/nrclinonc.2013.110 100 10.1038/nrclinonc.2013.110 false true Reference 67818104 /api/reference/67818104 101. Alix-Panabieres 2013: Circulating tumor cells: liquid biopsy of cancer., Clin Chem, 59, DOI: 10.1373/clinchem.2012.194258 101 10.1373/clinchem.2012.194258 false true Reference 67818105 /api/reference/67818105 102. Heitzer 2015: Circulating tumor DNA as a liquid biopsy for cancer., Clin Chem, 61, DOI: 10.1373/clinchem.2014.222679 102 10.1373/clinchem.2014.222679 false true Reference 67818106 /api/reference/67818106 103. Alix-Panabieres 2016: Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy., Cancer Discov, 6, DOI: 10.1158/2159-8290.CD-15-1483 103 10.1158/2159-8290.CD-15-1483 false true Reference 67818107 /api/reference/67818107 104. Karaszi 2019: Increased placental expression of Placental Protein 5 (PP5)/Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion., Placenta, 76, DOI: 10.1016/j.placenta.2019.01.011 104 10.1016/j.placenta.2019.01.011 false true Reference 67818108 /api/reference/67818108 105. Than 2014: Placental protein 13 (PP13) – A placental immunoregulatory galectin protecting pregnancy., Front Immunol, 5, DOI: 10.3389/fimmu.2014.00348 105 10.3389/fimmu.2014.00348 false true Reference 67818109 /api/reference/67818109 106. Balogh 2011: Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome., Am J Obstet Gynecol, 205, DOI: 10.1016/j.ajog.2011.03.023 106 10.1016/j.ajog.2011.03.023 false true Reference 67818110 /api/reference/67818110 107. Than 2008: Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome., Virchows Archiv, 453, p. 387, DOI: 10.1007/s00428-008-0658-x 107 10.1007/s00428-008-0658-x false true Reference 67818111 /api/reference/67818111 108. Than 2015: Galectins: double-edged swords in the cross-roads of pregnancy complications and female reproductive tract inflammation and neoplasia., J Pathol Trans Med, 49, p. 181, DOI: 10.4132/jptm.2015.02.25 108 10.4132/jptm.2015.02.25 false true Reference 67818112 /api/reference/67818112 109. Romero 2008: First-trimester maternal serum PP13 in the risk assessment for preeclampsia., Am J Obstet Gynecol, 199, DOI: 10.1016/j.ajog.2008.01.013 109 10.1016/j.ajog.2008.01.013 false true Reference 67818113 /api/reference/67818113 110. Than 2011: PP13, maternal ABO blood groups and the risk assessment of pregnancy complications., PloS One, 6, DOI: 10.1371/journal.pone.0021564 110 10.1371/journal.pone.0021564 false true Reference 67818114 /api/reference/67818114 111. Balogh 2019: Placental galectins are key players in regulating the maternal adaptive immune response., Front Immunol, 10, p. 1240, DOI: 10.3389/fimmu.2019.01240 111 10.3389/fimmu.2019.01240 false true Reference 67818115 /api/reference/67818115 112. Than 1993: Advances in Pregnancy-Related Protein Research 112 false true Reference 67818116 /api/reference/67818116 113. Vokalova 2020: Placental protein 13 (Galectin-13) polarizes neutrophils toward an immune regulatory phenotype., Front Immunol, 11, DOI: 10.3389/fimmu.2020.00145 113 10.3389/fimmu.2020.00145 false true Reference 67818117 /api/reference/67818117 114. Aebersold 2016: Mass-spectrometric exploration of proteome structure and function., Nature, 537, DOI: 10.1038/nature19949 114 10.1038/nature19949 false true Reference 67818118 /api/reference/67818118 115. Manna 2023: A proteomic profile of the healthy human placenta., Clin Proteomics, 20, p. 1, DOI: 10.1186/s12014-022-09388-4 115 10.1186/s12014-022-09388-4 false true Reference 67818119 /api/reference/67818119 116. Tarca 2022: Human plasma proteome during normal pregnancy., J Proteome Res, 21, DOI: 10.1021/acs.jproteome.2c00391 116 10.1021/acs.jproteome.2c00391 false true Reference 67818120 /api/reference/67818120 117. Michela 2021: Liquid biopsy: A family of possible diagnostic tools., Diagnostics, 11, p. 391, DOI: 10.3390/diagnostics11081391 117 10.3390/diagnostics11081391 false true Reference 67818121 /api/reference/67818121 118. Masserdotti 2024: Unveiling the human fetal-maternal interface during the first trimester: biophysical knowledge and gaps., Front Cell Dev Biol, 12, DOI: 10.3389/fcell.2024.1411582 118 10.3389/fcell.2024.1411582 false true Reference 67818122 /api/reference/67818122 119. Lo 1998: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis., Am J Hum Genet, 62, DOI: 10.1086/301800 119 10.1086/301800 false true Reference 67818123 /api/reference/67818123 120. Sarker 2014: Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy., J Trans Med, 12, p. 204, DOI: 10.1186/1479-5876-12-204 120 10.1186/1479-5876-12-204 false true Reference 67818124 /api/reference/67818124 121. Mayhew 2004: Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies., Placenta, 25, DOI: 10.1016/j.placenta.2003.10.010 121 10.1016/j.placenta.2003.10.010 false true Reference 67818125 /api/reference/67818125 122. Kaufmann 2004: Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy., Placenta, 25, DOI: 10.1016/j.placenta.2003.10.009 122 10.1016/j.placenta.2003.10.009 false true Reference 67818126 /api/reference/67818126 123. Burton 2004: Placental oxidative stress: from miscarriage to preeclampsia., J Soc Gynecol Invest, 11, DOI: 10.1016/j.jsgi.2004.03.003 123 10.1016/j.jsgi.2004.03.003 false true Reference 67818127 /api/reference/67818127 124. Gude 2004: Growth and function of the normal human placenta., Thromb Res, 114, p. 397, DOI: 10.1016/j.thromres.2004.06.038 124 10.1016/j.thromres.2004.06.038 false true Reference 67818128 /api/reference/67818128 125. Singh 2010: Assembly of fibronectin extracellular matrix., Annu Rev Cell Dev Biol, 26, p. 397, DOI: 10.1146/annurev-cellbio-100109-104020 125 10.1146/annurev-cellbio-100109-104020 false true Reference 67818129 /api/reference/67818129 126. Smits 1997: The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization., Genomics, 45, DOI: 10.1006/geno.1997.4918 126 10.1006/geno.1997.4918 false true Reference 67818130 /api/reference/67818130 127. Posey 2018: Cartilage oligomeric matrix protein: COMPopathies and beyond., Matrix Biol, DOI: 10.1016/j.matbio.2018.02.023 127 10.1016/j.matbio.2018.02.023 false true Reference 67818131 /api/reference/67818131 128. Aidoudi 2010: Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis., Thromb Haemostasis, 104, DOI: 10.1160/TH10-03-0193 128 10.1160/TH10-03-0193 false true Reference 67818132 /api/reference/67818132 129. Forstner 2021: Changes in maternal platelet physiology during gestation and their interaction with trophoblasts., Int J Mol Sci, 22, p. 10732, DOI: 10.3390/ijms221910732 129 10.3390/ijms221910732 false true Reference 67818133 /api/reference/67818133 130. Nawathe 2016: Insulin-like growth factor axis in pregnancies affected by fetal growth disorders., Clin Epigenetics, 8, p. 11, DOI: 10.1186/s13148-016-0178-5 130 10.1186/s13148-016-0178-5 false true Reference 67818134 /api/reference/67818134 131. Skornicka 2004: Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production., Cell Immunol, 232, DOI: 10.1016/j.cellimm.2005.03.007 131 10.1016/j.cellimm.2005.03.007 false true Reference 67818135 /api/reference/67818135 132. Lob 2021: Pregnancy Zone Protein (PZP) is significantly upregulated in the decidua of recurrent and spontaneous miscarriage and negatively correlated to Glycodelin A (GdA)., J Reprod Immunol, 143, p. 103267, DOI: 10.1016/j.jri.2020.103267 132 10.1016/j.jri.2020.103267 false true Reference 67818136 /api/reference/67818136 133. Aghababaei 2014: A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development., Mol Hum Reprod, 20, DOI: 10.1093/molehr/gat084 133 10.1093/molehr/gat084 false true Reference 67818137 /api/reference/67818137 134. Moore 2022: Pregnancy-specific glycoproteins: evolution, expression, functions and disease associations., Reprod, 163, DOI: 10.1530/REP-21-0390 134 10.1530/REP-21-0390 false true Reference 67818138 /api/reference/67818138 135. Fei 2018: Fibronectin (FN) cooperated with TLR2/TLR4 receptor to promote innate immune responses of macrophages binding to integrin beta1., Virulence, 9, DOI: 10.1080/21505594.2018.1528841 135 10.1080/21505594.2018.1528841 false true Reference 67818139 /api/reference/67818139 136. Horne 1976: Pregnancy specific beta1-glycoprotein–a product of the syncytiotrophoblast., Experientia, 32, p. 1197, DOI: 10.1007/BF01927624 136 10.1007/BF01927624 false true Reference 67818140 /api/reference/67818140 137. Snyder 2001: Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes., Am J Reprod Immunol, 45, DOI: 10.1111/j.8755-8920.2001.450403.x 137 10.1111/j.8755-8920.2001.450403.x false true Reference 67818141 /api/reference/67818141 138. Wan 2007: ‘Yin-Yang’ functions of transforming growth factor-beta and T regulatory cells in immune regulation., Immunol Rev, 220, p. 199, DOI: 10.1111/j.1600-065X.2007.00565.x 138 10.1111/j.1600-065X.2007.00565.x false true Reference 67818142 /api/reference/67818142 139. Liu 2021: ADAM12 is a costimulatory molecule that determines Th1 cell fate and mediates tissue inflammation., Cell Mol Immunol, 18, DOI: 10.1038/s41423-020-0486-8 139 10.1038/s41423-020-0486-8 false true Reference 67818143 /api/reference/67818143 140. Teirila 2019: Regulation of the complement system and immunological tolerance in pregnancy., Semin Immunol, 45, p. 101337, DOI: 10.1016/j.smim.2019.101337 140 10.1016/j.smim.2019.101337 false true Reference 67818144 /api/reference/67818144 141. Lee 2016: The pleiotropic effect of glycodelin-A in early pregnancy., Am J Reprod Immunol, 75, DOI: 10.1111/aji.12471 141 10.1111/aji.12471 false true Reference 67818145 /api/reference/67818145 142. Rachmilewitz 2003: Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45., J Biol Chem, 278, DOI: 10.1074/jbc.M211716200 142 10.1074/jbc.M211716200 false true Reference 67818146 /api/reference/67818146 143. Seppala 2002: Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation., Endocrine Rev, 23, DOI: 10.1210/er.2001-0026 143 10.1210/er.2001-0026 false true Reference 67818147 /api/reference/67818147 144. Sylvers-Davie 2021: Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8., Am J Physiol Endocrinol Metab, 321, DOI: 10.1152/ajpendo.00195.2021 144 10.1152/ajpendo.00195.2021 false true Reference 67818148 /api/reference/67818148 145. Camenisch 2002: ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo., J Biol Chem, 277, DOI: 10.1074/jbc.M109768200 145 10.1074/jbc.M109768200 false true Reference 67818149 /api/reference/67818149 146. Greinacher 2023: Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity., Int J Lab Hemost, p. 11, DOI: 10.1111/ijlh.14075 146 10.1111/ijlh.14075 false true Reference 67818150 /api/reference/67818150 147. Ji 2025: Platelet factor 4: A mysterious chemokine in inflammatory regulation diseases., J Inflam Res, 18, DOI: 10.2147/JIR.S504673 147 10.2147/JIR.S504673 false true Reference 67818151 /api/reference/67818151 148. Wu 2025: Pregnancy zone protein, a potential research target in multiple diseases., Gene, 935, p. 149013, DOI: 10.1016/j.gene.2024.149013 148 10.1016/j.gene.2024.149013 false true Reference 67818152 /api/reference/67818152 149. Erez 2009: Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes., J Matern Fetal Neonatal Med, 22, DOI: 10.3109/14767050902994796 149 10.3109/14767050902994796 false true Reference 67818153 /api/reference/67818153 150. Lob 2022: The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients., J Reprod Immunol, 153, p. 103663, DOI: 10.1016/j.jri.2022.103663 150 10.1016/j.jri.2022.103663 false true Reference 67818154 /api/reference/67818154 151. Papamichail 2022: Importance of low pregnancy associated plasma protein-A (PAPP-A) levels during the first trimester as a predicting factor for adverse pregnancy outcomes: A prospective cohort study of 2636 pregnant women., Cureus, 14, DOI: 10.7759/cureus.31256 151 10.7759/cureus.31256 false true Reference 67818155 /api/reference/67818155 152. Xu 2020: Preconception Hb concentration with risk of spontaneous abortion: a population-based cohort study in over 3.9 million women across rural China., Public Health Nutr, 23, DOI: 10.1017/S1368980019003811 152 10.1017/S1368980019003811 false true Reference 67818156 /api/reference/67818156 153. Diaz-Lopez 2021: High and low haemoglobin levels in early pregnancy are associated to a higher risk of miscarriage: A population-based cohort study., Nutrients, 13, DOI: 10.3390/nu13051578 153 10.3390/nu13051578 false true Reference 67818157 /api/reference/67818157 154. Schumacher 2017: Human chorionic gonadotropin as a pivotal endocrine immune regulator initiating and preserving fetal tolerance., Int J Mol Sci, 18, DOI: 10.3390/ijms18102166 154 10.3390/ijms18102166 false true Reference 67818158 /api/reference/67818158 155. Martinez 2013: The role of pregnancy-specific glycoprotein 1a (PSG1a) in regulating the innate and adaptive immune response., Am J Reprod Immunol, 69, DOI: 10.1111/aji.12089 155 10.1111/aji.12089 false true Reference 67818159 /api/reference/67818159 156. Takeuchi 1993: Free testosterone and abortion in early pregnancy., Int J Gynaecol Obstet, 43, DOI: 10.1016/0020-7292(93)90322-N 156 10.1016/0020-7292(93)90322-N false true Reference 67818160 /api/reference/67818160 157. Balogh 2019: Sex hormone-binding globulin provides a novel entry pathway for estradiol and influences subsequent signaling in lymphocytes via membrane receptor., Sci Rep, 9, p. 4, DOI: 10.1038/s41598-018-36882-3 157 10.1038/s41598-018-36882-3 false true Reference 67818161 /api/reference/67818161 158. Pijnenborg 2006: The uterine spiral arteries in human pregnancy: facts and controversies., Placenta, 27, DOI: 10.1016/j.placenta.2005.12.006 158 10.1016/j.placenta.2005.12.006 false true Reference 67818162 /api/reference/67818162 159. Burton 2009: Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy., Placenta, 30, DOI: 10.1016/j.placenta.2009.02.009 159 10.1016/j.placenta.2009.02.009 false true Reference 67818163 /api/reference/67818163 160. Jauniaux 2005: Pathophysiology of histological changes in early pregnancy loss., Placenta, 26, DOI: 10.1016/j.placenta.2004.05.011 160 10.1016/j.placenta.2004.05.011 false true Reference 67818164 /api/reference/67818164 161. Parker 2014: Mass spectrometry based biomarker discovery, verification, and validation–quality assurance and control of protein biomarker assays., Mol Oncol, 8, DOI: 10.1016/j.molonc.2014.03.006 161 10.1016/j.molonc.2014.03.006 false true Reference 67818165 /api/reference/67818165 162. Lehallier 2019: Undulating changes in human plasma proteome profiles across the lifespan., Nat Med, 25, DOI: 10.1038/s41591-019-0673-2 162 10.1038/s41591-019-0673-2 false true Reference 67818166 /api/reference/67818166 163. Tanaka 2018: Plasma proteomic signature of age in healthy humans., Aging Cell, 17, DOI: 10.1111/acel.12799 163 10.1111/acel.12799 false true /api/publication/36313869 Tóth Eszter et al. Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface. (2025) FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224 16<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10025667"><a href="/gui2/?type=authors&mode=browse&sel=10025667" target="_blank">Tóth Eszter (<span class="authorship-author-name">Tóth Eszter</span> <span class="authorAux-mtmt"> Proteomika</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/<span title="Molekuláris Élettudományi Intézet">MÉI</span>/Lendület Reprodukció Rendszerbiológiája Kutatócsoport Enzim_416</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10082656"><a href="/gui2/?type=authors&mode=browse&sel=10082656" target="_blank">Posta Máté^* (<span class="authorship-author-name">Posta Máté</span> <span class="authorAux-mtmt"> Szülészet- és nőgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Bioinformatika Tanszék; <span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/<span title="Molekuláris Élettudományi Intézet">MÉI</span>/Lendület Reprodukció Rendszerbiológiája Kutatócsoport Enzim_416</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10019484"><a href="/gui2/?type=authors&mode=browse&sel=10019484" target="_blank">Györffy Dániel (<span class="authorship-author-name">Györffy Dániel</span> <span class="authorAux-mtmt"> Bioinformatika</span>) </a> </span> <span class="author-affil"><span title="Pázmány Péter Katolikus Egyetem">PPKE</span>/Információs Technológiai és Bionikai Kar; <span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/Molekuláris Élettudományi Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10081331"><a href="/gui2/?type=authors&mode=browse&sel=10081331" target="_blank">Oravecz Orsolya (<span class="authorship-author-name">Oravecz Orsolya</span> <span class="authorAux-mtmt"> biológia, immunológia, molekuláris biológia, mi...</span>) </a> </span> <span class="author-affil"><span title="Eötvös Loránd Tudományegyetem">ELTE</span>/<span title="Természettudományi Kar">TTK</span>/Biológia Doktori Iskola</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10100038"><a href="/gui2/?type=authors&mode=browse&sel=10100038" target="_blank">Farkas Emese (<span class="authorship-author-name">Farkas Emese</span> <span class="authorAux-mtmt"> reproduktív immunológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/<span title="Molekuláris Élettudományi Intézet">MÉI</span>/Lendület Reprodukció Rendszerbiológiája Kutatócsoport Enzim_416</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10019319"><a href="/gui2/?type=authors&mode=browse&sel=10019319" target="_blank">Balogh Andrea (<span class="authorship-author-name">Balogh Andrea</span> <span class="authorAux-mtmt"> Immunológia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Escher Claudia </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Bober Magdalena </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010376"><a href="/gui2/?type=authors&mode=browse&sel=10010376" target="_blank">Szilágyi András (<span class="authorship-author-name">Szilágyi András</span> <span class="authorAux-mtmt"> Bioinformatika</span>) </a> </span> <span class="author-affil"><span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/<span title="Molekuláris Élettudományi Intézet">MÉI</span>/Lendület Reprodukció Rendszerbiológiája Kutatócsoport Enzim_416</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hupuczi Petronella </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Veress Lajos </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Török Olga </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10034624"><a href="/gui2/?type=authors&mode=browse&sel=10034624" target="_blank">Nagy Sándor (<span class="authorship-author-name">Nagy Sándor</span> <span class="authorAux-mtmt"> szülészet-nőgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Széchenyi István Egyetem">SZE</span>/<span title="Egészség- és Sporttudományi Kar">ESK</span>/Szülészeti és Nőgyógyászati Tanszék</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Rinner Oliver </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Erez Offer </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="1373182"><a href="/gui2/?type=authors&mode=browse&sel=1373182" target="_blank">Papp Zoltán (<span class="authorship-author-name">Papp Zoltán</span> <span class="authorAux-mtmt"> Szülészet-nőgyógyászat, klinikai genetika</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Szülészeti és Nőgyógyászati Klinika">SZSZNK</span>/Szülészeti és Nőgyógyászati Klinika Baross utcai részleg</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10013998"><a href="/gui2/?type=authors&mode=browse&sel=10013998" target="_blank">Ács Nándor (<span class="authorship-author-name">Ács Nándor</span> <span class="authorAux-mtmt"> Szülészet-nőgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Szülészeti és Nőgyógyászati Klinika">SZSZNK</span>/Szülészeti és Nőgyógyászati Klinika Üllői úti részleg</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10011696"><a href="/gui2/?type=authors&mode=browse&sel=10011696" target="_blank">Than Nándor Gábor ✉ (<span class="authorship-author-name">Than Nándor Gábor</span> <span class="authorAux-mtmt"> Rendszerbiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Szülészeti és Nőgyógyászati Klinika">SZSZNK</span>/Szülészeti és Nőgyógyászati Klinika Baross utcai részleg; <span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/<span title="Molekuláris Élettudományi Intézet">MÉI</span>/Lendület Reprodukció Rendszerbiológiája Kutatócsoport Enzim_416; <span title="HUN-REN Természettudományi Kutatóközpont">HRN TTK</span>/Molekuláris Élettudományi Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36313869" target="_blank">Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface</a></div> <div> <span class="journal-title">FRONTIERS IN IMMUNOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1664-3224">1664-3224</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1664-3224">1664-3224</a>)</span>: <span class="journal-volume">16</span> <span class="page"> Paper 1621168. 18 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.3389/fimmu.2025.1621168" target="_blank" href="https://doi.org/10.3389/fimmu.2025.1621168"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001569279100001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001569279100001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="105015399247" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-105015399247"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="40948775" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=40948775&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_NONE" title=" Nincs "> <a style="color:blue" title="https://www.scopus.com/inward/record.uri?eid=2-s2.0-105015399247&doi=10.3389%2ffimmu.2025.1621168&partnerID=40&md5=590f1db41dbcdf3ff44276a5ef667e8e" target="_blank" href="https://www.scopus.com/inward/record.uri?eid=2-s2.0-105015399247&doi=10.3389%2ffimmu.2025.1621168&partnerID=40&md5=590f1db41dbcdf3ff44276a5ef667e8e"> Egyéb URL </a> </span> <span class="id identifier oa_NONE" title=" Nincs "> <a style="color:blue" title="https://www.scopus.com/pages/publications/105015399247?origin=resultslist" target="_blank" href="https://www.scopus.com/pages/publications/105015399247?origin=resultslist"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Immunology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Immunology and Allergy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 3</span> | Független: 3 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 2 | Scopus jelölt:&nbsp;3 | WoS/Scopus jelölt:&nbsp;3 | DOI jelölt:&nbsp;3 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;36313869&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 16 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36313869</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">WOS TAGGED</span> </div> <div class="funder"> (LP2014-7/2014,), (HUN-REN SA-83/2021) Támogató: HUN_REN, (K128262), (2024-2-1-1-EKÖP-2024-00004), (FIEK-16-1-2016-0005), (K124862), Piacvezérelt kutatás-fejlesztési és innovációs projektek támogatása(2020-1.1.2-PIACI-KFI-2021-00273) Támogató: Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal, (2024-1.2.3-HU-RIZONT-2024-00062), (2019-2.1.7-ERANET-2020-00014), ERA PerMed(2020-346 grant) Támogató: EU </div> <div class="lastModified">Utolsó módosítás: 2026.05.30. 19:14 Lévayné Deseő Katalin (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2026.05.28. 12:32 Lévayné Deseő Katalin (MTMT Központi admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Funding Agency and Grant Number: Hungarian Academy of Sciences (Momentum) [LP2014-7/2014, 2019-436]; Hungarian Research Network [HUN-REN SA-83/2021]; HUN-REN [TECH-2024-042]; Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund [OTKA-K128262, 2024-2-1-1-EKP-2024-00004, FIEK-16-1-2016-0005, OTKA-K124862, 2020-1.1.2-PIACI-KFI-2021-00273, 202...</pre> </div></div>